DK1051156T3 - Farmaceutiske præparater - Google Patents

Farmaceutiske præparater

Info

Publication number
DK1051156T3
DK1051156T3 DK99907477T DK99907477T DK1051156T3 DK 1051156 T3 DK1051156 T3 DK 1051156T3 DK 99907477 T DK99907477 T DK 99907477T DK 99907477 T DK99907477 T DK 99907477T DK 1051156 T3 DK1051156 T3 DK 1051156T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
Prior art date
Application number
DK99907477T
Other languages
Danish (da)
English (en)
Inventor
Nikki Thoennes Brooks
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1051156T3 publication Critical patent/DK1051156T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK99907477T 1998-02-06 1999-02-04 Farmaceutiske præparater DK1051156T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802472.2A GB9802472D0 (en) 1998-02-06 1998-02-06 Pharmaceutical compositions
PCT/EP1999/000663 WO1999039691A2 (en) 1998-02-06 1999-02-04 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DK1051156T3 true DK1051156T3 (da) 2003-06-23

Family

ID=10826520

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99907477T DK1051156T3 (da) 1998-02-06 1999-02-04 Farmaceutiske præparater

Country Status (39)

Country Link
US (1) US6641843B1 (es)
EP (1) EP1051156B1 (es)
JP (1) JP3560550B2 (es)
KR (1) KR100564854B1 (es)
CN (2) CN1296406A (es)
AP (1) AP1212A (es)
AR (1) AR017455A1 (es)
AT (1) ATE237309T1 (es)
AU (1) AU754255B2 (es)
BR (1) BR9907649A (es)
CA (1) CA2319010C (es)
CO (1) CO5070673A1 (es)
CZ (1) CZ299608B6 (es)
DE (1) DE69906934T2 (es)
DK (1) DK1051156T3 (es)
EA (1) EA002916B1 (es)
EE (1) EE04217B1 (es)
ES (1) ES2196779T3 (es)
GB (1) GB9802472D0 (es)
HK (1) HK1030552A1 (es)
HR (1) HRP20000530B1 (es)
HU (1) HU228315B1 (es)
ID (1) ID26215A (es)
IL (2) IL137403A0 (es)
IS (1) IS2200B (es)
MA (1) MA26604A1 (es)
MY (1) MY121043A (es)
NO (1) NO329041B1 (es)
NZ (1) NZ505811A (es)
PE (1) PE20000271A1 (es)
PL (1) PL194558B1 (es)
PT (1) PT1051156E (es)
RS (1) RS49953B (es)
SI (1) SI1051156T1 (es)
SK (1) SK284397B6 (es)
TR (1) TR200002293T2 (es)
TW (1) TWI222878B (es)
WO (1) WO1999039691A2 (es)
ZA (1) ZA99890B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2080511A3 (en) * 2000-08-22 2009-09-30 Shire LLC Active agent delivery systems and methods for protecting and administering active agents
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
EP2085397A1 (en) * 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
EP2305680A3 (en) * 2009-09-30 2011-05-18 Aurobindo Pharma Limited Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
CN104788451A (zh) * 2014-01-21 2015-07-22 浙江九洲药业股份有限公司 一种阿巴卡韦的制备方法
CN105315280A (zh) * 2014-06-06 2016-02-10 上海迪赛诺化学制药有限公司 一种阿巴卡韦结晶体及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5567703A (en) 1988-01-20 1996-10-22 Regents Of The University Of Minnesota Method for treating HIV infections with dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
KR20000022225A (ko) * 1996-06-25 2000-04-25 그레이엄 브레레톤;레슬리 에드워즈 Hiv 치료에 사용하기 위한 vx478, 지도부딘 및(또는)1592u89를 포함하는 배합물
US6124319A (en) * 1997-01-21 2000-09-26 Merck & Co., Inc. 3,3-disubstituted piperidines as modulators of chemokine receptor activity
US6177464B1 (en) * 1997-03-14 2001-01-23 Sepracor, Inc. Ring opening metathesis of alkenes
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt

Also Published As

Publication number Publication date
EE200000459A (et) 2002-02-15
AP1212A (en) 2003-11-12
ATE237309T1 (de) 2003-05-15
PL194558B1 (pl) 2007-06-29
DE69906934T2 (de) 2004-02-12
NO329041B1 (no) 2010-08-02
HUP0100802A2 (hu) 2001-08-28
CZ20002867A3 (cs) 2001-02-14
IL137403A (en) 2007-07-24
AP2000001878A0 (en) 2000-09-30
JP2002502808A (ja) 2002-01-29
CN1296406A (zh) 2001-05-23
ID26215A (id) 2000-12-07
TR200002293T2 (tr) 2000-11-21
YU48200A (sh) 2003-02-28
PT1051156E (pt) 2003-09-30
HRP20000530B1 (en) 2003-10-31
CZ299608B6 (cs) 2008-09-17
AU754255B2 (en) 2002-11-07
SI1051156T1 (en) 2003-08-31
PE20000271A1 (es) 2000-04-17
ES2196779T3 (es) 2003-12-16
AR017455A1 (es) 2001-09-05
SK11682000A3 (sk) 2001-04-09
NO20003962L (no) 2000-09-27
AU2722199A (en) 1999-08-23
WO1999039691A2 (en) 1999-08-12
WO1999039691A3 (en) 1999-10-28
KR100564854B1 (ko) 2006-03-30
HU228315B1 (en) 2013-03-28
PL342628A1 (en) 2001-06-18
HRP20000530A2 (en) 2001-02-28
CA2319010C (en) 2008-06-10
EP1051156A2 (en) 2000-11-15
NO20003962D0 (no) 2000-08-04
IS5569A (is) 2000-07-20
ZA99890B (en) 2000-08-04
BR9907649A (pt) 2000-10-31
IS2200B (is) 2007-02-15
RS49953B (sr) 2008-09-29
US6641843B1 (en) 2003-11-04
DE69906934D1 (de) 2003-05-22
NZ505811A (en) 2002-09-27
CA2319010A1 (en) 1999-08-12
MA26604A1 (fr) 2004-12-20
GB9802472D0 (en) 1998-04-01
EA200000736A1 (ru) 2001-04-23
CN101239063A (zh) 2008-08-13
HUP0100802A3 (en) 2001-12-28
CO5070673A1 (es) 2001-08-28
SK284397B6 (sk) 2005-03-04
EE04217B1 (et) 2004-02-16
JP3560550B2 (ja) 2004-09-02
EA002916B1 (ru) 2002-10-31
TWI222878B (en) 2004-11-01
EP1051156B1 (en) 2003-04-16
MY121043A (en) 2005-12-30
IL137403A0 (en) 2001-07-24
KR20010040714A (ko) 2001-05-15
HK1030552A1 (en) 2001-05-11

Similar Documents

Publication Publication Date Title
DE69917956D1 (de) Tintenzuführsystemadapter
ATE341990T1 (de) Sigmidoskop
DE69911432D1 (de) Abgasrückfürungseinrichtung
NO20011191D0 (no) Vedlikeholdsfrigivelses-ranolazinformuleringer
DE59902874D1 (de) Buchsenkontakt
DE69924838D1 (de) Einlasslufterhitzmodule
DE69933073D1 (de) Informationsaufzeichnungsträgercassette
ID23735A (id) Tablet trovafloksasin mesilat
DE69811890D1 (de) Einzellenkalorimeter
DE69940418D1 (de) Tonsignalsmischung
ATE262513T1 (de) Benzoylpyridazine
NO20004309D0 (no) HÕrmiddel
FI980564A0 (fi) Volymregleringsorgan foer stroemningsroer
FI980251A0 (fi) Breddstraeckvals
DK1051156T3 (da) Farmaceutiske præparater
DE69942000D1 (de) Sicherheitstontaube
DE69808524T2 (de) Refinerplattensegment
FI980335A0 (fi) Statisk elenergimaetare
SE9801216D0 (sv) Pharmaceuticals
DE59911641D1 (de) Radaufhängungs-tester
NO20010996D0 (no) 2-okso-2H-kinolinderivater
SE9800469D0 (sv) Pharmaceuticals
DK0969815T3 (da) Farmaceutiske præparater
SE9702958D0 (sv) Pharmaceuticals
SE9902945D0 (sv) Pharmaceuticals